Voyageur Minerals Ltd.

0.07

Canada & Alberta Calgary

339 50th Avenue SE, Suite 255

+1 587 779-6166

www.voyageurminerals.ca

Looking to explore investment opportunities with VM?

Contact VM >

Looking to explore investment opportunities with VM?

Contact VM >

Is this your business?
Customize your listing.

CLAIM THIS LISTING

Is this your business?
Customize your listing.

Company Resources

Project : Frances Creek
Deposit : Frances Creek
Date : Jul 05, 2018
Report Code : NI43-101 Report Type: Resource Estimation
Download: View this Report
Commodities : Barite
Report Details: Updated mineral resource estimated at the project
Resources: (Resource): 166210t @ 37.75% BaSO4 (Ind.), 195578t @ 35.40% BaSO4 (Inf.)
CP/QP: [Resources]: Brad Willis (Internal)

Company Press Releases

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development

CALGARY, Alberta, May 11, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce it has signed an LOI with an established international mining company (the “Counterparty”) that has developed a low cost method to extract the natural occurring carbon molecule, C-60 to C-90, from  large natural-occurring fullerene resources. The technology to extract C-60 from natural fullerene deposits is ground-breaking and a first in this industry. “Voyageur will be the f...

Voyageur Announces Year-End Audited Financial Statements & MD&A

(TheNewswire) CALGARY, Alberta – TheNewswire- April 3rd,2020 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the “Company” or “Voyageur”) (formally Voyageur Minerals Ltd.) is pleased to announce the filing of its 2019 year-end audited Financial Statements and MD&A. The Company's Financial Statements and MD&A are available on SEDAR (www.sedar.com). About Voyageur Voyageur Pharmaceuticals Ltd. is Canadian public company listed on the TSX Venture Exchange under the trading symbol VM. Voyageur is focused on the development of barite and iodine A...

Voyageur Announces the Postponement of Filing Annual Financial Statements and MD&A due to COVID-19 related delays. Reschedules for April 3, 2020

(TheNewswire) CALGARY, Alberta - TheNewswire - March 27th, 2020 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) (formally Voyageur Minerals Ltd.) announces the postponement of filing its annual financial statements (“Financial Statements”) and its annual management's discussion & analysis (“MD&A”) for the year ended November 30, 2019 due to logistics and delays caused by the COVID-19. Voyageur will invoke the Alberta Securities Commission (the “Commission”) blanket order 51...

See All >

Company News

See All >